Scotts (SMG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2025, Scotts Miracle-Gro (SMG) reported revenue of $1.42 billion, down 6.8% over the same period last year. EPS came in at $3.98, compared to $3.69 in the year-ago quarter.The reported revenue represents a surprise of -5.15% over the Zacks Consensus Estimate of $1.5 billion. With the consensus EPS estimate being $3.95, the EPS surprise was +0.76%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Scotts performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- U.S.Consumer: $1.31 billion compared to the $1.37 billion average estimate based on five analysts. The reported number represents a change of -5% year over year. Net Sales- Other: $76.80 million compared to the $76.74 million average estimate based on five analysts. The reported number represents a change of -3% year over year. Net Sales- Hawthorne: $32.70 million versus $54.86 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -50.8% change. Segment Profit (Loss) (Non-GAAP)- U.S. Consumer: $392.50 million compared to the $390.69 million average estimate based on three analysts. Segment Profit (Loss) (Non-GAAP)- Hawthorne: -$0.90 million versus the three-analyst average estimate of $0.99 million. Segment Profit (Loss) (Non-GAAP)- Other: $9 million compared to the $2.80 million average estimate based on three analysts. Segment Profit (Loss) (Non-GAAP)- Corporate: -$34.80 million versus the two-analyst average estimate of -$33.34 million. View all Key Company Metrics for Scotts here>>>Shares of Scotts have returned -2.3% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Scotts Miracle-Gro Company (SMG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks